Abstract
Introduction
Oxidant and free radical attacks damage the cardiovascular cells and system, which causes inappropriate cellular proliferation and apoptosis. To get rid of the oxidant and free radical damage, cells have to develop self-defence antioxidant mechanisms, but due to continuous free radical attacks, this mechanism gets impaired and the cells require antioxidants to rejuvenate themselves. Nature has provided many ways to acquire antioxidants from various sources such as plants and herbs. One such important herb is Bacopa monnieri. B. monnieri is known as Brahmi or Jalnimba in India. B. monnieri is a potent, established Ayurvedic (antioxidant) medicine valued for its diverse roles in the treatment of various challenging diseases of the modern world and its anti-aging property 1, 2 . Plant antioxidants are a complex group of enzymes essential for repair of damaged DNA, damaged cell membrane, damaged protein and oxidized lipids and peroxides; they also stop chain propagation of peroxyl lipid radicals. These enzymes repair the damage to biomolecules and reconstitute the damaged cell membrane, e.g. lipase, protease, DNA repair enzymes, transferase and methionine sulphoxide reductase 2 . B. monnieri extract (BME) and its isolates have been extensively inves-tigated for their neuropharmacolog-ical effects 3 . However, research related to the role of BME in cultured vascular endothelial cell proliferation has not yet been investigated. In this study, we developed an endothelial cell culture model to investigate the mitogenic properties of BME and the significance of their role in human umbilical vein endothelial cell (HUVEC) proliferation.
Materials and methods
The protocol of this study has been approved by the relevant ethical committee related to our institution in which it was performed. BME Crude methanolic extract was prepared from fresh, clean, washed and dried B. monnieri herb as per the protocol of Phrompittayarata et al. 2 .
HUVEC expansion study for control (without any treatment)
Cell count was taken using a haemocytometer. To study the HUVEC proliferation rate, HUVECs were diluted to a cell density of 1 × 10 4 cells/mL and seeded. One millilitre of 20% endothelial cell growth medium was added to all the wells, and the plate was incubated in 5% CO 2 incubator. Cell count was taken on the second and twelfth day. Graph was plotted as follows: number of days (x-axis) vs. HUVEC proliferation ( y-axis) along with dosage of treatments.
HUVEC expansion study for treatments HUVECs were treated with H 2 O 2 (100 µM) for 1 h, BME (100 µg) for 2 h, pre-BME (100 µg) for 2 h plus post-H 2 O 2 (100 µM) for 1 h and pre-H 2 O 2 (100 µM) for 1 h plus post-BME (100 µg) for 2 h. HUVECs were diluted to a cell density of 1 × 10 4 cells/mL and seeded. Cell count was taken on the second and twelfth day. Cell count was taken using a haemocytometer. Graph was plotted as follows: 
Results

BME
Twelve grams of sticky crude BME was obtained and stored in the refrigerator and used for experiments.
HUVEC expansion and cell counts
HUVEC cell count for day 0 was 1 × 10 4 cells, and it showed 70% confluence with an expansion rate of 1.60312 × 10 5 on the twelfth day for the control group of cells (Figure 1 ). H 2 O 2 (100 µM; oxidative stress) treatment for 1 h resulted in a cell count of 1.51972 × 10 5 cell/cm 2 on the twelfth day (Figure 2 ). BME (100 µg) treatment for 2 h resulted in a cell count of 1.982 × 10 5 cell/cm 2 on the twelfth day (Figure 3 ). Pre-BME (100 µg) treatment for 2 h plus post-H 2 O 2 (100 µM) treatment for 1 h resulted in a cell count of 1.96121 × 10 5 cell/ cm 2 on the twelfth day ( Figure 4 ). Pre-H 2 O 2 (100 µM) treatment for 1 h plus post-BME (100 µg) treatment for 2 h resulted in a cell count of 1.50772 × 10 5 on the twelfth day ( Figures 5 and 6 ). some alkaloids including brahmine, herpestine and acid A 4 . A lag phase after seeding is followed by a period of exponential growth called the log phase. The attachment of cells to each other and to culture substrate is mediated by cell surface glycoproteins and Ca 2+ . Routine passage leads to standard growth cycle. It is essential to become familiar with this cycle for each endothelial cell that is cultured as it controls the seeding concentration, the duration of growth before subculture, the duration of experiments and the appropriate times for sampling to achieve highest consistency 5 . For control culture, i.e. without any treatment, HUVEC count was maximum on the twelfth day. In comparison with the control cells, a 1-h treatment of HUVECs with H 2 O 2 (100 µM) resulted in a decreased cell count on the twelfth day. HUVEC cell count dramatically increased after a 2-h treatment with BME compared with that for cells in the control group. Based on these observations, it was proved that BME (100 µg) dose exposure enhances cell growth or provides a mitogenic factor that enhances HUVEC proliferation in culture. In comparison with the control, HUVEC count was maximum on the twelfth day following pre-BME (100 µg) treatment for 2 h plus post-H 2 O 2 (100 µM) treatment for 1 h. This provides evidence that a dose of pre-BME exposure provides protection to HUVEC cellular organelles and its membrane from post-H 2 O 2 exposure attack and supports cellular proliferation. HUVEC count was less in comparison with the control on the twelfth day following treatment with pre-H 2 O 2 (100 µM) for 1 h plus post-BME (100 µg) treatment for 2 h. This shows that because of free radical attack, i.e. H 2 O 2 treatment, maximum cell injury occurs, but post-BME dose exposure, repair of cellular macromolecules and other cytosol organelles is facilitated. These provide necessary antioxidants that help the attacked cells and HUVECs, consequently leading to normal and healthy cellular proliferation.
Discussion
Conclusion
This finally concludes that BME has some beneficial antioxidant and mitogenic properties that play a significant role in HUVEC proliferation and rejuvenation of cells.
